デフォルト表紙
市場調査レポート
商品コード
1439292

脊椎インプラント - 世界市場の考察、競合情勢、市場予測(2030年)

Spinal Implants - Market Insights, Competitive Landscape, and Market Forecast - 2030

出版日: 受注後更新 | 発行: DelveInsight | ページ情報: 英文 150 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=158.16円
脊椎インプラント - 世界市場の考察、競合情勢、市場予測(2030年)
出版日: 受注後更新
発行: DelveInsight
ページ情報: 英文 150 Pages
納期: 2~10営業日
ご注意事項 :
本レポートの納品は、最新情報反映のため受注時に適宜更新しお届けいたします。
更新情報の反映作業にあたり納期もレポート毎に異なりますので、ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の脊椎インプラントの市場規模は、2023年に130億1,000万米ドル、2030年までに178億4,000万米ドルに達し、2024年~2030年の予測期間にCAGRで5.40%の成長が見込まれます。脊椎インプラントの需要の増加は、世界中の高齢者層における脊柱管狭窄症、椎間板ヘルニア、椎間板変性症などのさまざまな脊椎疾患の有病率の増加が主な原因です。さらに、骨移植製品の技術の進歩への注目の移行、脊椎疾患とその適切な管理に関する患者の意識の高まり、低侵襲手術への選好の高まりなどが、脊椎インプラント市場の促進要因となっています。

脊椎インプラントの市場力学

脊椎インプラントの需要は、交通事故や転倒、高齢化による脊椎関連の変形に悩む人々が世界中で増加しているため、かつてない勢いで伸びています。World Population Ageing 2020 Highlightsの統計によると、世界中で65歳以上の人口の割合は2020年の9.3%から2050年までに約16.0%に増加すると予測されています。高齢化が進むと、椎間板変性症や脊柱管狭窄症などの脊椎変形を発症しやすくなります。例えば、2020年にNCBIで発表されたWu L.とCruz R.による研究「Lumbar Spinal Stenosis」によると、後天性腰部脊柱管狭窄症の有病率は、60歳~69歳の人口で19.4%でした。

さらに、非政府組織であるSpinal Cord Injuries Australiaの2022年の統計によると、オーストラリアの人口のうち約1万5,000人が脊髄損傷を抱えて生活しており、交通事故が全症例の46%を占めるのに対し、転倒は外傷性SCIの全症例の約36%を占めています。

さらに、標準的な観血手術と比較して、切開創が小さく、筋肉損傷が少なく、出血量や手術後の在院日数が減少するなどの利点があるため、低侵襲脊椎手術に対する需要が急増していることも、予測期間の世界の脊椎インプラントデバイスに寄与する見込みです。

このように、前述のすべての要因が、世界の脊椎インプラント市場を強化する可能性が高いです。

しかし、インプラントの厳しい規制や、手術だけでなくデバイスも高額であることなどの特定の要因が、脊椎インプラント市場の成長を妨げる可能性が高いです。

脊椎インプラント市場のセグメント分析

脊椎インプラント製品セグメントでは、脊椎固定デバイスが予測期間に最大の市場シェアを占めると予測されます。これは、市場で幅広い種類の脊椎固定デバイスが入手可能なためです。また、世界中で腰椎変性の有病率が増加していることも、このセグメント市場の活性化につながると予測されます。2018年に発表されたRavindra M.V.らによるNCBIの調査「Degenerative Lumbar Spine Disease: Estimating Global Incidence and Worldwide Volume」によると、世界で合計2億6,600万人(3.63%)が毎年腰椎変性脊椎疾患(DSD)と腰痛(LBP)を患っています。

さらに、先進技術を備えた脊椎固定デバイスのポートフォリオにおける近年の製品承認も、このセグメント市場に拍車をかけると予測されます。例えば2020年8月、Innovasisは、HAnano Surfaceを持つ多孔性脊椎間体デバイスで初のSpecial 510(k)認可を取得しました。新たに承認されたInnovasisのマイクロ多孔質3Dプリントチタン製デバイスには、前方腰椎椎体間固定術(ALIF)向けのスタンドアロンIBFデバイスであるAxTiHA(TM)システムが含まれます。

北米が脊椎インプラント市場全体を独占すると予測されます。

予測期間に北米が脊椎インプラント市場全体を独占すると予測されます。この優位性は、この地域における脊椎手術に対する確立された償還シナリオによるものです。さらに、適切な先進の医療施設のプレゼンスや、この地域における腰痛の有病率の上昇も、この地域の市場の促進要因となっています。

当レポートでは、世界の脊椎インプラント市場について調査分析し、市場規模と予測、促進要因と課題、企業と製品のプロファイルなどを提供しています。

目次

第1章 脊椎インプラントレポートのイントロダクション

第2章 脊椎インプラントのエグゼクティブサマリー

  • 調査範囲
  • 市場の概要
  • 競合の評価
  • 財務ベンチマーク

第3章 規制と特許の分析

  • 米国
  • 欧州
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • 英国
  • 日本

第4章 脊椎インプラント市場の主な要因の分析

  • 脊椎インプラント市場の促進要因
    • 世界中での脊椎変形の有病率の増加
    • 骨移植製品の技術の進歩
    • 低侵襲手術の需要の増加
    • 脊椎疾患の管理に関する人々の意識の高まり
  • 脊椎インプラント市場の抑制要因と課題
    • 厳格な規制当局の承認プロセス
    • 少数の製品リコール
  • 脊椎インプラント市場の機会
    • 3D技術の導入による機会の拡大
    • 経済的発展途上国における市場成長の機会

第5章 脊椎インプラントのポーターのファイブフォース分析

第6章 脊椎インプラント市場に対するCOVID-19の影響分析

第7章 脊椎インプラント市場のレイアウト

  • 製品タイプ別
    • 脊椎固定デバイス
    • 可動性温存/非固定デバイス
    • 脊椎圧迫骨折治療デバイス/脊椎増強デバイス
    • 脊椎向け生物学的製剤
  • エンドユーザー別
    • 病院
    • 整形外科クリニック
    • その他
  • 地域別
    • 北米
    • 欧州
  • アジア太平洋
    • その他の地域

第8章 脊椎インプラント:世界の企業シェア分析 - 主要3~5社

第9章 脊椎インプラントの企業と製品のプロファイル

  • Zimmer Biomet
  • Medtronic
  • RTI Surgical
  • Orthofix Medical Inc.
  • DePuy Synthes (Johnson & Johnson)
  • NuVasive Inc.
  • Globus Medical
  • Captiva Spine, Inc.
  • B. Braun Melsungen AG
  • XTANT MEDICAL
  • Stryker Corporation
  • Medacta International
  • ATEC Spine, Inc
  • Advin Health Care
  • Auxein Medical.
  • Aurora Spine
  • Spineology Inc.
  • Camber Spine Technologies, LLC
  • Exactech, Inc.
  • Life Spine, Inc.

第10章 プロジェクトのアプローチ

  • 二次資料
  • 一次資料
  • データの三角測量
  • 主な専門家の意見

第11章 KOLの見解

第12章 DelveInsightのサービス内容

第13章 免責事項

第14章 DelveInsightについて

図表

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: COVID-19 Impact Analysis on Spinal Implants Market
  • Table 3: Spinal Implants Market Analysis in Global (2021-2030)
  • Table 4: Spinal Implants Market Analysis in Global by Product Type (2021-2030)
  • Table 5: Spinal Implants Market Analysis in Global by End User (2021-2030)
  • Table 6: Spinal Implants Market Analysis in Global by Geography (2021-2030)
  • Table 7: Spinal Implants Market Analysis in North America (2021-2030)
  • Table 8: Spinal Implants Market Analysis in North America by Product Type (2021-2030)
  • Table 9: Spinal Implants Market Analysis in North America by End User (2021-2030)
  • Table 10: Spinal Implants Market Analysis in North America by Country (2021-2030)
  • Table 11: Spinal Implants Market Analysis in the US (2021-2030)
  • Table 12: Spinal Implants Market Analysis in Canada (2021-2030)
  • Table 13: Spinal Implants Market Analysis in Mexico (2021-2030)
  • Table 14: Spinal Implants Market Analysis in Europe (2021-2030)
  • Table 15: Spinal Implants Market Analysis in Europe by Product Type (2021-2030)
  • Table 16: Spinal Implants Market Analysis in Europe by End User (2021-2030)
  • Table 17: Spinal Implants Market Analysis in Europe by Country (2021-2030)
  • Table 18: Spinal Implants Market Analysis in France (2021-2030)
  • Table 19: Spinal Implants Market Analysis in Germany (2021-2030)
  • Table 20: Spinal Implants Market Analysis in the UK (2021-2030)
  • Table 21: Spinal Implants Market Analysis in Italy (2021-2030)
  • Table 22: Spinal Implants Market Analysis in Spain (2021-2030)
  • Table 23: Spinal Implants Market Analysis in Russia (2021-2030)
  • Table 24: Spinal Implants Market Analysis in Rest of Europe (2021-2030)
  • Table 25: Spinal Implants Market Analysis in Asia-Pacific (2021-2030)
  • Table 26: Spinal Implants Market Analysis in Asia-Pacific by Product Type (2021-2030)
  • Table 27: Spinal Implants Market Analysis in Asia-Pacific by End User (2021-2030)
  • Table 28: Spinal Implants Market Analysis in Asia-Pacific by Country (2021-2030)
  • Table 29: Spinal Implants Market Analysis in China (2021-2030)
  • Table 30: Spinal Implants Market Analysis in Japan (2021-2030)
  • Table 31: Spinal Implants Market Analysis in India (2021-2030)
  • Table 32: Spinal Implants Market Analysis in Australia (2021-2030)
  • Table 33: Spinal Implants Market Analysis in South Korea (2021-2030)
  • Table 34: Spinal Implants Market Analysis in Rest of Asia-Pacific (2021-2030)
  • Table 35: Spinal Implants Market Analysis in Rest of World (2021-2030)
  • Table 36: Spinal Implants Market Analysis in Rest of World by Product Type (2021-2030)
  • Table 37: Spinal Implants Market Analysis in Rest of World by End User (2021-2030)
  • Table 38: Spinal Implants Market Analysis in Rest of World by Country (2021-2030)
  • Table 39: Spinal Implants Market Analysis in Middle East (2021-2030)
  • Table 40: Spinal Implants Market Analysis in Africa (2021-2030)
  • Table 41: Spinal Implants Market Analysis in South America (2021-2030)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: COVID-19 Impact Analysis on Spinal Implants Market
  • Figure 3: Spinal Implants Market Analysis in Global (2021-2030)
  • Figure 4: Spinal Implants Market Analysis in Global by Product Type (2021-2030)
  • Figure 5: Spinal Implants Market Analysis in Global by End User (2021-2030)
  • Figure 6: Spinal Implants Market Analysis in Global by Geography (2021-2030)
  • Figure 7: Spinal Implants Market Analysis in North America (2021-2030)
  • Figure 8: Spinal Implants Market Analysis in North America by Product Type (2021-2030)
  • Figure 9: Spinal Implants Market Analysis in North America by End User (2021-2030)
  • Figure 10: Spinal Implants Market Analysis in North America by Country (2021-2030)
  • Figure 11: Spinal Implants Market Analysis in the US (2021-2030)
  • Figure 12: Spinal Implants Market Analysis in Canada (2021-2030)
  • Figure 13: Spinal Implants Market Analysis in Mexico (2021-2030)
  • Figure 14: Spinal Implants Market Analysis in Europe (2021-2030)
  • Figure 15: Spinal Implants Market Analysis in Europe by Product Type (2021-2030)
  • Figure 16: Spinal Implants Market Analysis in Europe by End User (2021-2030)
  • Figure 17: Spinal Implants Market Analysis in Europe by Country (2021-2030)
  • Figure 18: Spinal Implants Market Analysis in France (2021-2030)
  • Figure 19: Spinal Implants Market Analysis in Germany (2021-2030)
  • Figure 20: Spinal Implants Market Analysis in the UK (2021-2030)
  • Figure 21: Spinal Implants Market Analysis in Italy (2021-2030)
  • Figure 22: Spinal Implants Market Analysis in Spain (2021-2030)
  • Figure 23: Spinal Implants Market Analysis in Russia (2021-2030)
  • Figure 24: Spinal Implants Market Analysis in Rest of Europe (2021-2030)
  • Figure 25: Spinal Implants Market Analysis in Asia-Pacific (2021-2030)
  • Figure 26: Spinal Implants Market Analysis in Asia-Pacific by Product Type (2021-2030)
  • Figure 27: Spinal Implants Market Analysis in Asia-Pacific by End User (2021-2030)
  • Figure 28: Spinal Implants Market Analysis in Asia-Pacific by Country (2021-2030)
  • Figure 29: Spinal Implants Market Analysis in China (2021-2030)
  • Figure 30: Spinal Implants Market Analysis in Japan (2021-2030)
  • Figure 31: Spinal Implants Market Analysis in India (2021-2030)
  • Figure 32: Spinal Implants Market Analysis in Australia (2021-2030)
  • Figure 33: Spinal Implants Market Analysis in South Korea (2021-2030)
  • Figure 34: Spinal Implants Market Analysis in Rest of Asia-Pacific (2021-2030)
  • Figure 35: Spinal Implants Market Analysis in Rest of World (2021-2030)
  • Figure 36: Spinal Implants Market Analysis in Rest of World by Product Type (2021-2030)
  • Figure 37: Spinal Implants Market Analysis in Rest of World by End User (2021-2030)
  • Figure 38: Spinal Implants Market Analysis in Rest of World by Country (2021-2030)
  • Figure 39: Spinal Implants Market Analysis in Middle East (2021-2030)
  • Figure 40: Spinal Implants Market Analysis in Africa (2021-2030)
  • Figure 41: Spinal Implants Market Analysis in South America (2021-2030)
  • Figure 42: Market Drivers
  • Figure 43: Market Barriers
  • Figure 44: Market Opportunities
  • Figure 45: PORTER's Five Force Analysis
目次
Product Code: DIMDCL0082

Spinal Implants Market By Product Type (Spinal Fusion & Fixation Devices [Thoracolumbar Devices, Cervical Fixation Devices, and Interbody Fusion Devices], Motion Preservation/Non-Fusion Devices [Artificial Disc Replacement, Dynamic Stabilization Devices, Annulus Repair Devices, and Others], Vertebral Compression Fracture Treatment Devices/Spine Augmentation Devices [Vertebroplaty Devices, Balloon Kyphoplasty Devices], Spine Biologics [Demineralized Bone Matrix, Bone Morphogenetic Proteins, Allografts, and Others]), By End-User (Hospitals, Orthopedic Clinics, and Others), By Geography is anticipated to expand at a modest CAGR forecast till 2030 due to rising prevalence of spinal disorders and technological advancement in the field of spinal implants.

The global Spinal Implants Market was valued at USD 13.01 billion in 2023, growing at a CAGR of 5.40% during the forecast period from 2024 to 2030 to reach USD 17.84 billion by 2030. The rise in demand for Spinal Implants is predominantly attributed due to the increasing prevalence of various spinal disorders which include spinal stenosis, disc herniation, and degenerative disc diseases, among others in the older population across the globe. Moreover, shifting focus towards technological advancement in bone graft products, rising awareness among the patient population regarding spinal disorder and their proper management, and rising preferences for minimally invasive surgeries are the factors driving the spinal implants market.

Spinal Implants Market Dynamics:

The demand for the spinal implants are growing at an unprecedented rate because of the rising population suffering with spinal related deformities caused due to road traffic crashes, falls, or increasing age across the globe. The world population is aging, according to the statistics of World Population Ageing 2020 Highlights, globally, the share of the population aged 65 years or over is expected to increase from 9.3 % in 2020 to around 16.0 % in 2050. Rising aging population are more susceptible to develop spinal deformities such as degenerative disc disorders, spinal stenosis, and others. For instance, according to a study: Lumbar Spinal Stenosis by Wu L. and Cruz R. published in NCBI in the year 2020, the prevalence of acquired lumbar spinal stenosis was 19.4% for the population aged between 60 and 69 years.

Moreover, according to the 2022 statistics of the Spinal Cord Injuries Australia, a non-government organization, approximately 15000 of the Australian population live with a spinal cord injury and traffic crashes contribute to 46% of all the cases whereas falls contribute to around 36% of all the traumatic SCI cases.

In addition, burgeoning demand for the minimally invasive spinal surgical procedures owing to the advantages such as smaller incisions, less muscle damage, decreased blood loss and length of hospital stay following surgery in comparison to standard open approach will also contribute to the global spinal implant devices during the forecasted period.

Thus, all the aforementioned factors are likely to bolster the global spinal implants market.

However, certain factors such as stringent regulatory for the implants and high cost of the devices as well as surgery are likely to hinder the spinal implants market growth.

Spinal Implants Market Segment Analysis:

Spinal Implants Market By Product Type (Spinal Fusion & Fixation Devices [Thoracolumbar Devices, Cervical Fixation Devices, and Interbody Fusion Devices], Motion Preservation/Non-Fusion Devices [Artificial Disc Replacement, Dynamic Stabilization Devices, Annulus Repair Devices, and Others], Vertebral Compression Fracture Treatment Devices/Spine Augmentation Devices [Vertebroplaty Devices, Balloon Kyphoplasty Devices], Spine Biologics [Demineralized Bone Matrix, Bone Morphogenetic Proteins, Allografts, and Others]), By End-User (Hospitals, Orthopedic Clinics, and Others), and by Geography (North America, Europe, Asia-Pacific, and Rest of the World).

In the Spinal Implants product segment, spinal fusion and fixation devices are expected to hold a largest market share during the forecast period. This is due to the availability of a wide range of spinal fusion and fixation devices in the market. Also, increasing lumbar spine degeneration prevalence across the globe is expected to fuel the segmental market. According to a NCBI study: Degenerative Lumbar Spine Disease: Estimating Global Incidence and Worldwide Volume by Ravindra M.V. et al., published in the year 2018, a total of 266 million individuals (3.63%) worldwide were found to have Lumbar degenerative spine disease (DSD) and low back pain (LBP) annually.

Furthermore, recent product approvals in spinal fusion and fixation device portfolio with advanced technology is also expected to spur the segmental market. For instance, in August 2020, Innovasis receives first special 510(k) clearance for porous spinal interbody device with HAnano Surface. The newly approved Innovasis micro porous 3D printed titanium devices include the AxTiHA(TM) System, a standalone IBF device for Anterior Lumbar Interbody Fusion (ALIF).

North America is expected to dominate the overall Spinal Implants Market:

North America is expected to dominate the overall Spinal Implants market during the forecast period. This domination is due to the existence of well-established reimbursement scenario for spinal surgeries in the region. In addition, presence of proper and advanced healthcare facilities, and rising prevalence of low back pain in the region is also a factor driving the market in the region.

Further, In the United States, the rising spinal cord injury is also expected to propel the spinal implants market. According to the National SCI Statistical Center 2018, people in the United States the annual incidence of spinal cord injury (SCI) is approximately 54 cases per one million or about 17,700 new SCI cases each year.

In addition, rising spinal surgery volume is also a factor that is anticipated to augment the spinal implant devices in the region. According to a study: Predicting Trends in Cervical Spinal Surgery in the United States from 2020 to 2040 by Neifert S.N. et al., published in NCBI in the year 2020, it was expected that there would be an increase of 13.3% and 19.3% for anterior cervical discectomy and fusion (ACDF) and posterior cervical decompression and fusion (PCDF) from the year 2020-2040.

Moreover, product approvals in the region will also contribute to the spinal implants market in the region. For instance, in August 2020, Orion Biotech Inc. received the US Food & Drug Administration (FDA) approval for Thoracolumbosacral Pedicle Screw System intended to provide posterior, non-cervical immobilization and stabilization of spinal segments in skeletally mature patients.

Further, the Asia-Pacific region has the future potential growth for the Global Spinal Implants. This is due to the increasing per capita healthcare expenditure, improving healthcare infrastructure, rising disposable income, high burden of spine fractures in the region is projected to augment the spinal market in the region. For instance, according to a study: The Burden of Spine Fractures in India by Aleem S.I. et al., in NCBI in the year 2017, most middle aged patients experienced fracture in the lumbar spine region (51%) followed by thoracic (30.7%) and cervical (18.2%).

Spinal Implants Market Key Players:

Some of the key market players operating in the Spinal Fusion Devices market includes Medtronic, Johnson & Johnson, Zimmer Biomet, Stryker Corporation, B. Braun Melsungen AG, NuVasive®, Inc., Orthofix Medical Inc., XTANT MEDICAL, RTI Surgical, Life Spine, Inc., Globus Medical, Captiva Spine, Inc., Medacta International, ATEC Spine, Inc, Advin Health Care, Auxein Medical, Aurora Spine, Spineology Inc., Camber Spine Technologies, LLC, Exactech, Inc., and others.

Recent Developmental Activities in the Spinal Implants Market:

In August 2022, Aurora Spine Corporation received FDA 510(k) clearance for DEXA-C(TM) Cervical Interbody System.

In August 2022, Camber Spine received FDA 510(k) clearance for both its SPIRA-P Posterior Lumbar Spacer technology and SPIRA-T Oblique Posterior Lumbar Spacer technologies.

In March 2022, Aurora Spine Corporation successfully launched its Proprietary SiLO(TM) Posterior SI Joint Fusion System.

In October 2020, Medtronic launched Adaptix Interbody System, a navigated titanium implant with Titan nanoLOCK surface technology, a blend of surface textures on the macro, micro, and nano levels.

Key Takeaways from the Spinal Implants Market Report Study

Market size analysis for current market size (2023), and market forecast for 5 years (2024-2030)

The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the Spinal Implants market.

Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years

Key companies dominating the Global Spinal Implants Market.

Various opportunities available for the other competitor in the Spinal Implants Market space.

What are the top-performing segments in 2023? How these segments will perform in 2030.

Which are the top-performing regions and countries in the current market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for Spinal Implants market growth in the coming future?

Target Audience who can be benefited from Spinal Implants Market Report Study

Spinal Implants providers

Research organizations and consulting companies

Spinal Implants-related organization, association, forum, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders in Spinal Implants

Various End-users who want to know more about the Spinal Implants Market and the latest technological developments in the Spinal Implants market.

Frequently Asked Questions for Spinal Implants Market:

1. What are Spinal Implants?

Spinal implants are devices surgeons use during surgery to treat deformity, stabilize and strengthen the spine, and facilitate fusion. Disorders treated using spinal implants include degenerative disc disease, scoliosis, kyphosis, spondylolisthesis, and fracture

2. What is the market for Global Spinal Implants?

Global Spinal Implants Market was valued at USD 13.01 billion in 2023, growing at a CAGR of 5.40% during the forecast period from 2024 to 2030 to reach USD 17.84 billion by 2030.

3. What are the drivers for Global Spinal Implants?

The major factors driving the demand for Spinal Implants are the growing geriatric population coupled with the rising spine deformities, increased preferences for minimally invasive surgeries, technological advancement, among others.

4. What are the key players operating in Global Spinal Implants?

Some of the key market players operating in the Spinal Fusion Devices market includes Medtronic, Johnson & Johnson Services, Inc., Zimmer Biomet, Stryker Corporation, B. Braun Melsungen AG, NuVasive®, Inc., Orthofix Medical Inc., XTANT MEDICAL, RTI Surgical, Life Spine, Inc., Globus Medical, Captiva Spine, Inc., Medacta International, ATEC Spine, Inc, Advin Health Care, Auxein Medical, Aurora Spine, Spineology Inc., Camber Spine Technologies, LLC, Exactech, Inc., and others.

5. Which region have the highest share in Spinal Implants market?

North America is expected to dominate the overall Spinal Implants market during the forecast period 2024-2030. This domination is due to the existence of well-established reimbursement scenario for spinal surgeries in the region. In addition, presence of proper and advanced healthcare facilities, and rising prevalence of low back pain in the region is also a factor driving the market in the region.

Table of Contents

1. Spinal Implants Report Introduction

2. Spinal Implants Executive summary

  • 2.1. Scope of the Study
  • 2.2. Market at Glance
  • 2.3. Competitive Assessment
  • 2.4. Financial Benchmarking

3. Regulatory and Patent Analysis

  • 3.1. The United States
  • 3.2. Europe
    • 3.2.1. Germany
    • 3.2.2. France
    • 3.2.3. Italy
    • 3.2.4. Spain
    • 3.2.5. U.K.
  • 3.3. Japan

4. Spinal Implants Market Key factors analysis

  • 4.1. Spinal Implants Market Drivers
    • 4.1.1. Increasing prevalence of spine deformities across the globe
    • 4.1.2. Technological advancement in the bone grafting products
    • 4.1.3. Increase in demand for minimally invasive surgeries
    • 4.1.4. Rising awareness among the population related to spine disorder management
  • 4.2. Spinal Implants Market Restraints and Challenges
    • 4.2.1. Stringent regulatory approval process
    • 4.2.2. Few product recalls
  • 4.3. Spinal Implants Market Opportunities
    • 4.3.1. Growing opportunities with introduction of 3D technology
    • 4.3.2. Market growth opportunities in economically developing nations

5. Spinal Implants Porter's Five Forces Analysis

  • 5.1. Bargaining Power of Suppliers
  • 5.2. Bargaining Power of Consumers
  • 5.3. Threat of New Entrants
  • 5.4. Threat of Substitutes
  • 5.5. Competitive Rivalry

6. COVID-19 Impact Analysis on Spinal Implants Market

7. Spinal Implants Market layout

  • 7.1. By Product Type
    • 7.1.1. Spinal Fusion and Fixation Devices
      • 7.1.1.1. Thoracolumbar Devices
      • 7.1.1.2. Cervical Fixation Devices
      • 7.1.1.3. Interbody Fusion Devices
    • 7.1.2. Motion Preservation/Non-fusion Devices
      • 7.1.2.1. Artificial Discs Replacement
      • 7.1.2.2. Dynamic Stabilization Devices
      • 7.1.2.3. Annulus Repair Devices
      • 7.1.2.4. Others
    • 7.1.3. Vertebral Compression Fracture Treatment Devices/Spine augmentation Devices
      • 7.1.3.1. Vertebroplaty Devices
      • 7.1.3.2. Balloon Kyphoplasty Devices
    • 7.1.4. Spine Biologics
      • 7.1.4.1. Demineralized Bone Matrix
      • 7.1.4.2. Bone Morphogenetic Proteins
      • 7.1.4.3. Allografts
      • 7.1.4.4. Others
  • 7.2. By End-user
    • 7.2.1. Hospitals
    • 7.2.2. Orthopedic Clinics
    • 7.2.3. Others
  • 7.3. By Geography
    • 7.3.1. North America
      • 7.3.1.1. North America Spinal Implants Market, by Product Type
      • 7.3.1.2. North America Spinal Implants Market, by End User
      • 7.3.1.3. North America Spinal Implants Market, by Country
      • 7.3.1.4.1. United States
      • 7.3.1.4.2. Canada
      • 7.3.1.4.3. Mexico
    • 7.3.2. Europe
      • 7.3.2.1. Europe Spinal Implants Market, by Product Type
      • 7.3.2.2. Europe Spinal Implants Market, by End User
      • 7.3.2.3. Europe Spinal Implants Market, by Country
      • 7.3.2.4.1. France
      • 7.3.2.4.2. Germany
      • 7.3.2.4.3. United Kingdom
      • 7.3.2.4.4. Italy
      • 7.3.2.4.5. Spain
      • 7.3.2.4.6. Russia
      • 7.3.2.4.7. Rest of Europe
  • 7.3. Asia-Pacific
      • 7.3.3.1. Asia-Pacific Spinal Implants Market, by Product Type
      • 7.3.3.2. Asia-Pacific Spinal Implants Market, by End User
      • 7.3.3.3. Asia-Pacific Spinal Implants Market, by Country
      • 7.3.3.4.1. China
      • 7.3.3.4.2. Japan
      • 7.3.3.4.3. India
      • 7.3.3.4.4. Australia
      • 7.3.3.4.5. South Korea
      • 7.3.3.4.6. Rest of Asia Pacific
    • 7.3.4. Rest of the World (RoW)
      • 7.3.4.1. RoW Spinal Implants Market, by Product Type
      • 7.3.4.2. RoW Spinal Implants Market, by End User
      • 7.3.4.3. RoW Spinal Implants Market, by Region
      • 7.3.4.4.1. Middle East
      • 7.3.4.4.2. Africa
      • 7.3.4.4.3. South America

8. Spinal Implants Global Company Share Analysis - Key 3-5 Companies

9. Spinal Implants Company and Product Profiles

  • 9.1. Zimmer Biomet
    • 9.1.1. Company Overview
    • 9.1.2. Company Snapshot
    • 9.1.3. Financial Overview
    • 9.1.4. Product Listing
    • 9.1.5. Entropy
  • 9.2. Medtronic
    • 9.2.1. Company Overview
    • 9.2.2. Company Snapshot
    • 9.2.3. Financial Overview
    • 9.2.4. Product Listing
    • 9.2.5. Entropy
  • 9.3. RTI Surgical
    • 9.3.1. Company Overview
    • 9.3.2. Company Snapshot
    • 9.3.3. Financial Overview
    • 9.3.4. Product Listing
    • 9.3.5. Entropy
  • 9.4. Orthofix Medical Inc.
    • 9.4.1. Company Overview
    • 9.4.2. Company Snapshot
    • 9.4.3. Financial Overview
    • 9.4.4. Product Listing
    • 9.4.5. Entropy
  • 9.5. DePuy Synthes (Johnson & Johnson)
    • 9.5.1. Company Overview
    • 9.5.2. Company Snapshot
    • 9.5.3. Financial Overview
    • 9.5.4. Product Listing
    • 9.5.5. Entropy
  • 9.6. NuVasive Inc.
    • 9.6.1. Company Overview
    • 9.6.2. Company Snapshot
    • 9.6.3. Financial Overview
    • 9.6.4. Product Listing
    • 9.6.5. Entropy
  • 9.7. Globus Medical
    • 9.7.1. Company Overview
    • 9.7.2. Company Snapshot
    • 9.7.3. Financial Overview
    • 9.7.4. Product Listing
    • 9.7.5. Entropy
  • 9.8. Captiva Spine, Inc.
    • 9.8.1. Company Overview
    • 9.8.2. Company Snapshot
    • 9.8.3. Financial Overview
    • 9.8.4. Product Listing
    • 9.8.5. Entropy
  • 9.9. B. Braun Melsungen AG
    • 9.9.1. Company Overview
    • 9.9.2. Company Snapshot
    • 9.9.3. Financial Overview
    • 9.9.4. Product Listing
    • 9.9.5. Entropy
  • 9.10. XTANT MEDICAL
    • 9.10.1. Company Overview
    • 9.10.2. Company Snapshot
    • 9.10.3. Financial Overview
    • 9.10.4. Product Listing
    • 9.10.5. Entropy
  • 9.11. Stryker Corporation
    • 9.11.1. Company Overview
    • 9.11.2. Company Snapshot
    • 9.11.3. Financial Overview
    • 9.11.4. Product Listing
    • 9.11.5. Entropy
  • 9.12. Medacta International
    • 9.12.1. Company Overview
    • 9.12.2. Company Snapshot
    • 9.12.3. Financial Overview
    • 9.12.4. Product Listing
    • 9.12.5. Entropy
  • 9.13. ATEC Spine, Inc
    • 9.13.1. Company Overview
    • 9.13.2. Company Snapshot
    • 9.13.3. Financial Overview
    • 9.13.4. Product Listing
    • 9.13.5. Entropy
  • 9.14. Advin Health Care
    • 9.14.1. Company Overview
    • 9.14.2. Company Snapshot
    • 9.14.3. Financial Overview
    • 9.14.4. Product Listing
    • 9.14.5. Entropy
  • 9.15. Auxein Medical.
    • 9.15.1. Company Overview
    • 9.15.2. Company Snapshot
    • 9.15.3. Financial Overview
    • 9.15.4. Product Listing
    • 9.15.5. Entropy
  • 9.16. Aurora Spine
    • 9.16.1. Company Overview
    • 9.16.2. Company Snapshot
    • 9.16.3. Financial Overview
    • 9.16.4. Product Listing
    • 9.16.5. Entropy
  • 9.17. Spineology Inc.
    • 9.17.1. Company Overview
    • 9.17.2. Company Snapshot
    • 9.17.3. Financial Overview
    • 9.17.4. Product Listing
    • 9.17.5. Entropy
  • 9.18. Camber Spine Technologies, LLC
    • 9.18.1. Company Overview
    • 9.18.2. Company Snapshot
    • 9.18.3. Financial Overview
    • 9.18.4. Product Listing
    • 9.18.5. Entropy
  • 9.19. Exactech, Inc.
    • 9.19.1. Company Overview
    • 9.19.2. Company Snapshot
    • 9.19.3. Financial Overview
    • 9.19.4. Product Listing
    • 9.19.5. Entropy
  • 9.20. Life Spine, Inc.
    • 9.20.1. Company Overview
    • 9.20.2. Company Snapshot
    • 9.20.3. Financial Overview
    • 9.20.4. Product Listing
    • 9.20.5. Entropy

10. Project Approach

  • 10.1. Secondary Sources
  • 10.2. Primary Sources
  • 10.3. Data Triangulation
  • 10.4. Key Expert Opinions

11. KOL Views

12. DelveInsight Capabilities

13. Disclaimer

14. About DelveInsight